Source Post

The creator highlights Precision Peptide Company (BPC) as a microcap stock following a business model simil...

Sep 29, 2026

The creator highlights Precision Peptide Company (BPC) as a microcap stock following a business model similar to Hims & Hers, noting potential regulatory tailwinds for their peptide products.

Linked Mentions

Tickers discussed in this post

HIMSNeutralLow ConvictionResearch Only

Hims & Hers is mentioned as a business model benchmark for Precision Peptide Company.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.